Connection

Stephen Ethier to Female

This is a "connection" page, showing publications Stephen Ethier has written about Female.
Connection Strength

0.786
  1. Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.
    View in: PubMed
    Score: 0.037
  2. Eukaryotic initiation factor 4E-binding protein as an oncogene in breast cancer. BMC Cancer. 2019 May 23; 19(1):491.
    View in: PubMed
    Score: 0.036
  3. Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3. Breast Cancer Res Treat. 2017 Jul; 164(2):349-358.
    View in: PubMed
    Score: 0.031
  4. Functional oncogene signatures guide rationally designed combination therapies to synergistically induce breast cancer cell death. Oncotarget. 2016 Jun 14; 7(24):36138-36153.
    View in: PubMed
    Score: 0.029
  5. Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERa in SUM-44 breast cancer cells and is associated with ERa over-expression in breast cancer. Mol Oncol. 2016 06; 10(6):850-65.
    View in: PubMed
    Score: 0.029
  6. Two members of the TRiC chaperonin complex, CCT2 and TCP1 are essential for survival of breast cancer cells and are linked to driving oncogenes. Exp Cell Res. 2015 Mar 15; 332(2):223-35.
    View in: PubMed
    Score: 0.027
  7. Oncogenic signaling in amphiregulin and EGFR-expressing PTEN-null human breast cancer. Mol Oncol. 2015 Feb; 9(2):527-43.
    View in: PubMed
    Score: 0.026
  8. KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer. Neoplasia. 2014 Aug; 16(8):644-55.
    View in: PubMed
    Score: 0.026
  9. Knock-down of amphiregulin inhibits cellular invasion in inflammatory breast cancer. J Cell Physiol. 2011 Oct; 226(10):2691-701.
    View in: PubMed
    Score: 0.021
  10. Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells. PLoS One. 2011 Mar 17; 6(3):e17959.
    View in: PubMed
    Score: 0.020
  11. Frequency and type of epidermal growth factor receptor mutations in African Americans with non-small cell lung cancer. J Thorac Oncol. 2011 Mar; 6(3):627-30.
    View in: PubMed
    Score: 0.020
  12. Transforming properties of 8p11-12 amplified genes in human breast cancer. Cancer Res. 2010 Nov 01; 70(21):8487-97.
    View in: PubMed
    Score: 0.020
  13. HER-2 signaling, acquisition of growth factor independence, and regulation of biological networks associated with cell transformation. Cancer Res. 2010 Oct 15; 70(20):7862-73.
    View in: PubMed
    Score: 0.019
  14. Methylation-associated silencing of SFRP1 with an 8p11-12 amplification inhibits canonical and non-canonical WNT pathways in breast cancers. Int J Cancer. 2009 Oct 01; 125(7):1613-21.
    View in: PubMed
    Score: 0.018
  15. Amphiregulin as a novel target for breast cancer therapy. J Mammary Gland Biol Neoplasia. 2008 Jun; 13(2):171-9.
    View in: PubMed
    Score: 0.017
  16. Transforming properties of TC-1 in human breast cancer: interaction with FGFR2 and beta-catenin signaling pathways. Int J Cancer. 2007 Sep 15; 121(6):1265-73.
    View in: PubMed
    Score: 0.016
  17. Activation of a nuclear factor kappaB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells. Mol Cancer Res. 2007 Aug; 5(8):847-61.
    View in: PubMed
    Score: 0.016
  18. Differential signal transduction of alternatively spliced FGFR2 variants expressed in human mammary epithelial cells. J Cell Physiol. 2007 Mar; 210(3):720-31.
    View in: PubMed
    Score: 0.015
  19. Multiple interacting oncogenes on the 8p11-p12 amplicon in human breast cancer. Cancer Res. 2006 Dec 15; 66(24):11632-43.
    View in: PubMed
    Score: 0.015
  20. Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. J Biol Chem. 2006 Dec 08; 281(49):37728-37.
    View in: PubMed
    Score: 0.015
  21. Transforming function of the LSM1 oncogene in human breast cancers with the 8p11-12 amplicon. Oncogene. 2007 Mar 29; 26(14):2104-14.
    View in: PubMed
    Score: 0.015
  22. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res. 2004 Jan 01; 64(1):40-7.
    View in: PubMed
    Score: 0.012
  23. Epidermal growth factor receptor signaling and response of cancer cells to ionizing radiation. J Natl Cancer Inst. 2001 Jun 20; 93(12):890-1.
    View in: PubMed
    Score: 0.010
  24. Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor. Int J Radiat Oncol Biol Phys. 2000 Dec 01; 48(5):1519-28.
    View in: PubMed
    Score: 0.010
  25. Heregulin-beta is especially potent in activating phosphatidylinositol 3-kinase in nontransformed human mammary epithelial cells. J Cell Physiol. 2000 Jun; 183(3):301-13.
    View in: PubMed
    Score: 0.010
  26. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE. Breast Cancer Res. 2000; 2(4):311-20.
    View in: PubMed
    Score: 0.010
  27. erbB-2 overexpression in human mammary epithelial cells confers growth factor independence. Endocrinology. 1999 Aug; 140(8):3615-22.
    View in: PubMed
    Score: 0.009
  28. Constitutive activation of pp125fak in newly isolated human breast cancer cell lines. Breast Cancer Res Treat. 1999 Mar; 54(2):173-82.
    View in: PubMed
    Score: 0.009
  29. Deletion of the murine ortholog of the 8q24 gene desert has anti-cancer effects in transgenic mammary cancer models. BMC Cancer. 2018 Dec 10; 18(1):1233.
    View in: PubMed
    Score: 0.009
  30. MYC Inhibition Depletes Cancer Stem-like Cells in Triple-Negative Breast Cancer. Cancer Res. 2017 12 01; 77(23):6641-6650.
    View in: PubMed
    Score: 0.008
  31. Role of epidermal growth factor receptor and STAT-3 activation in autonomous proliferation of SUM-102PT human breast cancer cells. Cancer Res. 1997 Mar 01; 57(5):978-87.
    View in: PubMed
    Score: 0.008
  32. Cancer-associated fibroblast-secreted CXCL16 attracts monocytes to promote stroma activation in triple-negative breast cancers. Nat Commun. 2016 10 11; 7:13050.
    View in: PubMed
    Score: 0.007
  33. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Cell Growth Differ. 1996 May; 7(5):551-61.
    View in: PubMed
    Score: 0.007
  34. MYC Is a Crucial Mediator of TGF?-Induced Invasion in Basal Breast Cancer. Cancer Res. 2016 06 15; 76(12):3520-30.
    View in: PubMed
    Score: 0.007
  35. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2. Mol Carcinog. 1996 Mar; 15(3):227-38.
    View in: PubMed
    Score: 0.007
  36. erbB family receptor expression and growth regulation in a newly isolated human breast cancer cell line. Cancer Res. 1996 Feb 15; 56(4):899-907.
    View in: PubMed
    Score: 0.007
  37. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha. Mol Carcinog. 1996 Feb; 15(2):134-43.
    View in: PubMed
    Score: 0.007
  38. Human breast cancer cell lines as models of growth regulation and disease progression. J Mammary Gland Biol Neoplasia. 1996 Jan; 1(1):111-21.
    View in: PubMed
    Score: 0.007
  39. Overexpression of GAB2 in ovarian cancer cells promotes tumor growth and angiogenesis by upregulating chemokine expression. Oncogene. 2016 08 04; 35(31):4036-47.
    View in: PubMed
    Score: 0.007
  40. Expression of functional toll like receptor 4 in estrogen receptor/progesterone receptor-negative breast cancer. Breast Cancer Res. 2015 Sep 22; 17:130.
    View in: PubMed
    Score: 0.007
  41. Perspectives on Epidermal Growth Factor Receptor Regulation in Triple-Negative Breast Cancer: Ligand-Mediated Mechanisms of Receptor Regulation and Potential for Clinical Targeting. Adv Cancer Res. 2015; 127:253-81.
    View in: PubMed
    Score: 0.007
  42. Finite proliferative lifespan in vitro of a human breast cancer cell strain isolated from a metastatic lymph node. Breast Cancer Res Treat. 1993 Dec; 28(3):267-76.
    View in: PubMed
    Score: 0.006
  43. Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell. 2013 Oct 14; 24(4):450-65.
    View in: PubMed
    Score: 0.006
  44. Global H3K27 trimethylation and EZH2 abundance in breast tumor subtypes. Mol Oncol. 2012 Oct; 6(5):494-506.
    View in: PubMed
    Score: 0.006
  45. ERLIN2 promotes breast cancer cell survival by modulating endoplasmic reticulum stress pathways. BMC Cancer. 2012 Jun 08; 12:225.
    View in: PubMed
    Score: 0.006
  46. Induction of proapoptotic antibodies to triple-negative breast cancer by vaccination with TRAIL death receptor DR5 DNA. Int J Cancer. 2012 Dec 01; 131(11):2562-72.
    View in: PubMed
    Score: 0.005
  47. Secretion of an epidermal growth factor-like growth factor by epidermal growth factor-independent rat mammary carcinoma cells. Cell Growth Differ. 1991 Nov; 2(11):593-602.
    View in: PubMed
    Score: 0.005
  48. Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 2011 Oct 01; 71(19):6195-207.
    View in: PubMed
    Score: 0.005
  49. Identification and functional analysis of 9p24 amplified genes in human breast cancer. Oncogene. 2012 Jan 19; 31(3):333-41.
    View in: PubMed
    Score: 0.005
  50. Forkhead transcription factor foxq1 promotes epithelial-mesenchymal transition and breast cancer metastasis. Cancer Res. 2011 Feb 15; 71(4):1292-301.
    View in: PubMed
    Score: 0.005
  51. Disulfiram treatment facilitates phosphoinositide 3-kinase inhibition in human breast cancer cells in vitro and in vivo. Cancer Res. 2010 May 15; 70(10):3996-4004.
    View in: PubMed
    Score: 0.005
  52. Secretion of a TGF-beta-like growth inhibitor by normal rat mammary epithelial cells in vitro. J Cell Physiol. 1990 Jan; 142(1):15-20.
    View in: PubMed
    Score: 0.005
  53. Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer. Oncogene. 2009 Dec 17; 28(50):4491-500.
    View in: PubMed
    Score: 0.005
  54. Distinct gene mutation profiles among luminal-type and basal-type breast cancer cell lines. Breast Cancer Res Treat. 2010 May; 121(1):53-64.
    View in: PubMed
    Score: 0.005
  55. cAMP levels in proliferating rat mammary epithelial cells in vitro and in vivo. Exp Cell Res. 1989 Jun; 182(2):653-8.
    View in: PubMed
    Score: 0.004
  56. Racial disparity in breast cancer and functional germ line mutation in galectin-3 (rs4644): a pilot study. Cancer Res. 2008 Dec 15; 68(24):10045-50.
    View in: PubMed
    Score: 0.004
  57. Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines. Breast Cancer Res Treat. 2009 Jan; 113(2):285-91.
    View in: PubMed
    Score: 0.004
  58. Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet. 2008 Jan; 40(1):102-7.
    View in: PubMed
    Score: 0.004
  59. Importance of extended growth potential and growth factor independence on in vivo neoplastic potential of primary rat mammary carcinoma cells. Cancer Res. 1987 Oct 15; 47(20):5316-22.
    View in: PubMed
    Score: 0.004
  60. p38MAPK-activated AKT in HER-2 overexpressing human breast cancer cells acts as an EGF-independent survival signal. J Surg Res. 2007 Sep; 142(1):162-9.
    View in: PubMed
    Score: 0.004
  61. Influence of hormone and growth factor interactions on the proliferative potential of normal rat mammary epithelial cells in vitro. J Cell Physiol. 1987 Jul; 132(1):161-7.
    View in: PubMed
    Score: 0.004
  62. A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. Cancer Cell. 2006 Dec; 10(6):515-27.
    View in: PubMed
    Score: 0.004
  63. Serum-free culture conditions for the growth of normal rat mammary epithelial cells in primary culture. In Vitro Cell Dev Biol. 1986 Aug; 22(8):485-90.
    View in: PubMed
    Score: 0.004
  64. New guidelines for reporting of tumor marker studies in breast cancer research and treatment: REMARK. Breast Cancer Res Treat. 2006 Nov; 100(2):237-8.
    View in: PubMed
    Score: 0.004
  65. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res. 2006 Jan 01; 66(1):41-5.
    View in: PubMed
    Score: 0.004
  66. Primary culture and serial passage of normal and carcinogen-treated rat mammary epithelial cells in vitro. J Natl Cancer Inst. 1985 Jun; 74(6):1307-18.
    View in: PubMed
    Score: 0.003
  67. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Cancer Res. 2004 Oct 15; 64(20):7237-40.
    View in: PubMed
    Score: 0.003
  68. Morphological and histological characteristics of mammary dysplasias occurring in cell dissociation-derived murine mammary outgrowths. Cancer Res. 1984 Oct; 44(10):4517-22.
    View in: PubMed
    Score: 0.003
  69. Factors influencing expression of mammary ductal dysplasia in cell dissociation-derived murine mammary outgrowths. Cancer Res. 1984 Oct; 44(10):4523-7.
    View in: PubMed
    Score: 0.003
  70. Transcriptome analysis of HER2 reveals a molecular connection to fatty acid synthesis. Cancer Res. 2003 Jan 01; 63(1):132-9.
    View in: PubMed
    Score: 0.003
  71. Detection of ductal dysplasia in mammary outgrowths derived from carcinogen-treated virgin female BALB/c mice. Cancer Res. 1982 May; 42(5):1753-60.
    View in: PubMed
    Score: 0.003
  72. Comparative genomic hybridization analysis of 38 breast cancer cell lines: a basis for interpreting complementary DNA microarray data. Cancer Res. 2000 Aug 15; 60(16):4519-25.
    View in: PubMed
    Score: 0.002
  73. SUM-159PT cells: a novel estrogen independent human breast cancer model system. Breast Cancer Res Treat. 1999 Dec; 58(3):193-204.
    View in: PubMed
    Score: 0.002
  74. Carcinogenic polycyclic aromatic hydrocarbons increase intracellular Ca2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis. 1997 Jun; 18(6):1177-82.
    View in: PubMed
    Score: 0.002
  75. BRCA1 protein level is not affected by peptide growth factors in MCF10A cell line. Oncogene. 1996 Dec 05; 13(11):2487-91.
    View in: PubMed
    Score: 0.002
  76. Presence of an insulin-like growth factor I autocrine loop predicts uterine fibroid responsiveness to tamoxifen. Cancer Res. 1996 Sep 01; 56(17):4049-55.
    View in: PubMed
    Score: 0.002
  77. Biological disposition and imaging of a radioiodinated alkylphosphocholine in two rodent models of breast cancer. J Nucl Med. 1996 Sep; 37(9):1540-5.
    View in: PubMed
    Score: 0.002
  78. Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med. 1996 Jun; 37(6):1042-7.
    View in: PubMed
    Score: 0.002
  79. Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med. 1995 Oct; 36(10):1854-61.
    View in: PubMed
    Score: 0.002
  80. Fluorine-18-fluorodeoxyglucose-guided breast cancer surgery with a positron-sensitive probe: validation in preclinical studies. J Nucl Med. 1995 Oct; 36(10):1869-74.
    View in: PubMed
    Score: 0.002
  81. Sensitive detection of occult breast cancer by the reverse-transcriptase polymerase chain reaction. J Clin Oncol. 1994 Mar; 12(3):475-82.
    View in: PubMed
    Score: 0.002
  82. Differential isolation of normal luminal mammary epithelial cells and breast cancer cells from primary and metastatic sites using selective media. Cancer Res. 1993 Feb 01; 53(3):627-35.
    View in: PubMed
    Score: 0.001
  83. The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. J Nucl Med. 1990 Nov; 31(11):1831-5.
    View in: PubMed
    Score: 0.001
  84. Enhanced in vitro proliferation and in vivo tumorigenic potential of mammary epithelium from BALB/c mice exposed in vivo to gamma-radiation and/or 7,12-dimethylbenz[a]anthracene. Cancer Res. 1987 Aug 15; 47(16):4425-31.
    View in: PubMed
    Score: 0.001
  85. Survival of mammary epithelial cells from virgin female BALB/c mice following in vivo gamma irradiation. Radiat Res. 1984 Nov; 100(2):264-72.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.